Anteo Diagnostics Ltd (ADO):企業の製品パイプライン分析2018

GlobalDataが発行した調査報告書(DATA904C7709)
◆英語タイトル:Anteo Diagnostics Ltd (ADO) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C7709
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinical diagnostic, and medical device markets, including a PoC test for the diagnosis of heart attacks (troponin test). It holds patents for nanometre-thin primers, binders, and coatings. Anteo Diagnostics’s patented nanoglue technology, Mix&Go, finds application in healthcare industry. The company is also investigating its nanoglue technology for attaching bio-molecules to synthetic surfaces and evaluating its potential in the manufacture of batteries. It has subsidiaries in Australia, Belgium and Spain. Anteo Diagnostics is headquartered in Brisbane, Queensland, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Anteo Diagnostics Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Anteo Diagnostics Ltd Company Overview 4
Anteo Diagnostics Ltd Company Snapshot 4
Anteo Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Anteo Diagnostics Ltd – Pipeline Analysis Overview 6
Business Description 6
Anteo Diagnostics Ltd – Key Facts 6
Anteo Diagnostics Ltd – Major Products and Services 7
Anteo Diagnostics Ltd Pipeline Products by Development Stage 8
Anteo Diagnostics Ltd Pipeline Products Overview 10
AtomoRapid – Heart Attack 10
AtomoRapid – Heart Attack Product Overview 10
Point of Care Tropical Disease Assay 11
Point of Care Tropical Disease Assay Product Overview 11
Point-Of-Care Bone Metabolism Assay 12
Point-Of-Care Bone Metabolism Assay Product Overview 12
Point-of-Care Infectious Disease Assay 13
Point-of-Care Infectious Disease Assay Product Overview 13
Point-Of-Care Troponin Test 14
Point-Of-Care Troponin Test Product Overview 14
Anteo Diagnostics Ltd – Key Competitors 15
Anteo Diagnostics Ltd – Key Employees 16
Anteo Diagnostics Ltd – Key Employee Biographies 17
Anteo Diagnostics Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Anteo Diagnostics Ltd, Recent Developments 19
Apr 27, 2018: Anteo Diagnostics: Activities Report – Quarter Ended 31 March 2018 19
Apr 09, 2018: Anteo Diagnostics: CEO Resignation and CEO Appointment 20
Apr 03, 2018: Anteo Diagnostics: Chairman Appointed and Board Changes 21
Jan 31, 2018: Activities Report – Quarter Ended 31 December 2017 21
Dec 06, 2017: Anteo Diagnostics: Appointment of Chief Executive Officer 23
Oct 31, 2017: Anteo Diagnostics: Activities Report – Quarter Ended 30 September 2017 24
Sep 01, 2017: Anteo Diagnostics: 30 June 2017 Preliminary Financial Statements 26
Sep 01, 2017: Management changes resulting from sale of DIAsource 27
Apr 28, 2017: Anteo Diagnostics: Quarterly Activities Report 27
Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 30
Appendix 31
Methodology 31
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Anteo Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Anteo Diagnostics Ltd Pipeline Products by Equipment Type 5
Anteo Diagnostics Ltd Pipeline Products by Indication 5
Anteo Diagnostics Ltd, Key Facts 6
Anteo Diagnostics Ltd, Major Products and Services 7
Anteo Diagnostics Ltd Number of Pipeline Products by Development Stage 8
Anteo Diagnostics Ltd Pipeline Products Summary by Development Stage 9
AtomoRapid - Heart Attack - Product Status 10
AtomoRapid - Heart Attack - Product Description 10
Point of Care Tropical Disease Assay - Product Status 11
Point of Care Tropical Disease Assay - Product Description 11
Point-Of-Care Bone Metabolism Assay - Product Status 12
Point-Of-Care Bone Metabolism Assay - Product Description 12
Point-of-Care Infectious Disease Assay - Product Status 13
Point-of-Care Infectious Disease Assay - Product Description 13
Point-Of-Care Troponin Test - Product Status 14
Point-Of-Care Troponin Test - Product Description 14
Anteo Diagnostics Ltd, Key Employees 16
Anteo Diagnostics Ltd, Key Employee Biographies 17
Anteo Diagnostics Ltd, Subsidiaries 18
Glossary 33

List of Figures
Anteo Diagnostics Ltd Pipeline Products by Equipment Type 5
Anteo Diagnostics Ltd Pipeline Products by Development Stage 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Anteo Diagnostics Ltd (ADO):企業の製品パイプライン分析2018(Anteo Diagnostics Ltd (ADO) - Product Pipeline Analysis, 2018 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆